10 April 2017

ELPA Symposium 2017: New Horizons in Liver Disease

What is Next for the Liver?
27 February 2017

Hep-CORE Press conference Highlights

European Liver Patients' Association released the 2016 Hep-CORE Report on the state of viral hepatitis policy and practice in Europe in Berlin on December 20th. This report, conducted under the direction of Prof. Jeffrey V. Lazarus of ISGlobal, University of Barcelona, reveals the sobering results showing that fifty-two per cent (52%) of surveyed European (25) and Mediterranean Basin (2) countries lack national strategies to address viral hepatitis B or C, despite the WHO World Health Assembly resolution calling on all countries to have one. Only three of these countries have access to the new, highly effective medicines (directacting antivirals) for hepatitis C without restrictions.
16 January 2017

ELPA Calls on Patients with Primary Liver Cancer (HCC) to Share their Experiences in First Global Survey

Results will provide doctors and cancer researchers with insights to improve liver cancer treatment now, and in the future
20 December 2016

The 2016 Hep-CORE Report

ELPA presents the stark findings of the 2016 Hep-CORE Report
12 December 2016

Serious Gaps in Viral Hepatitis Policies in Europe

Presentation of the 27-country Hep-CORE 2016 study results
9 September 2016

ELPA writes open letter to governments

We, the European Liver Patients Association representing patients with liver disease in Europe, would like to draw attention to the urgent public health problem of access to the latest medical therapies for the treatment of patients with hepatitis C.
26 July 2016

ELPA Launches Hep-CORE Study in Advance of World Hepatitis Day; Preliminary Data from Patient Groups Raise Concerns about Responses to HBV and HCV in Europe

BRUSSELS, BELGIUM, 26 JULY 2016 – The European Liver Patients Association (ELPA), in collaboration with a European research team, recently launched the Hep-CORE study to assess national responses to viral hepatitis in the region, collecting a preliminary dataset in advance of World Hepatitis Day (28 July 2016). The data, which were obtained by surveying ELPA member groups, suggest that some European countries are falling short in terms of the policies and practices that public health experts and the World Health Organization recommend as the basis for an effective response to the hepatitis B virus (HBV) and hepatitis C virus (HCV) epidemics.
1 July 2016

Article in Brussels Airlines inflight magazine

Dear visitors, look for our article on the page 82 of the Brussels Airlines inflight magazine.
1 June 2016

WHO Viral Hepatitis Strategy ADOPTION

The ELPA President has participated 69 World Health Assembly in Geneve where the adoption of the first ever Global Hepatitis Strategy took place on 28th of May at exactly 12:35 p.m.
1 May 2016

EASL ILC™ 2016

ELPA members had participated in various lectures, workshops and symposia at the International Liver Congress (ILCTM ) during the 51st annual meeting of the European Association for the Study of the Liver (EASL), held in Barcelona 13th – 17th April 2016.
1 April 2016

2016 ELPA Symposium

« New Hepatitis C antivirals: Is universal access still a dream? »
11 February 2016

Tatjana Reic and Ivan Gardini, President and Vice President of ELPA meet the European Commissioner for Health

Meeting between the European Commissioner for Health, Vytenis Andriukaitis, and Tatjana Reic and Ivan Gardini, President and Vice President of ELPA, on 11 January in Brussels, to discuss future EU policies with regard to hepatitis C and alcohol. The Commissioner recognises the opportunity to eliminate HCV and discussed possible opportunities within the limits of EU competence, respecting the subsidiarity principle.
12 March 2015

ELPA, with leading NGOs, issues open letter to Members of European Parliament

ELPA, together with other leading NGOs in the field of public health, issued an open letter to Members of the European Parliament, urging them to put public health at the forefront of the EU Alcohol Strategy Resolution.
2 October 2014

ELPA joins NGOs sending an Open letter To Heads of State and Government

ELPA joins NGOs sending an Open letter To Heads of State and Government of the European Union Member States on Pharmaceutical Policy.
26 September 2014

BMC Infectious Disease supplement “Viral Hepatitis and Drug Use in Europe” now available

The BMC Infectious Disease supplement “Viral Hepatitis and Drug Use in Europe” is now available online.
22 September 2014

Hepatitis C: Sit in of European patients to request access to new medicines, on occasion of the informal meeting of European Health Ministers in Milan

Hepatitis C: Sit in of European patients to request access to new medicines, on occasion of the informal meeting of European Health Ministers in Milan